Hyperice Introduces Hypervolt Go 2 as Everyday Wellness Essential for All
4.4.2022 13:00:00 EEST | Business Wire | Press release
Hyperice, a global high-performance wellness brand, today introduced a new and improved version of its original, award-winning handheld massage gun, the Hypervolt Go. Leveling up and standing on its own within the percussive massage category, the newly redesigned, lightweight and versatile Hypervolt Go 2 is the most sophisticated portable percussion massager to hit the wellness market and is built to increase people’s range of motion with just a five minute treatment each day1.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220404005376/en/
Hyperice Introduces Hypervolt Go 2 as Everyday Wellness Essential for All (Photo: Business Wire)
The Hypervolt Go 2 adds to the company’s range of powerful percussion devices including the recently launched Hypervolt 2 and Hypervolt 2 Pro, all of which help everyday users and pro athletes alike massage away stress and muscle tension from the palm of their hand.
“For over 10 years, Hyperice has been relentlessly focused on developing innovative products to help people across the globe move and live better. The new Hypervolt Go 2 offers a unique combination of performance and portability for the wellness-minded consumer,” said Jim Huether, CEO of Hyperice. “Designed for the everyday go-getter, the Hypervolt Go 2 is a wellness essential - perfect for everyone who is moving at home or on the road and wants to be at their best everyday.”
“The Hypervolt Go 2 is the result of our 'design first’ approach to creating a product that looks as good as it feels. We wanted to design a product that people would want to take and use everywhere they go,” said Anthony Katz, Founder and President of Hyperice. “With this newest addition to the Hypervolt family, the Hypervolt Go 2 offers more choice, to more people, in more places than ever before.”
WELLNESS THAT MOVES WITH YOU
The new Hypervolt Go 2 has a sophisticated design that features minimalistic looks with an arctic-grey finish and feels great in your hand and on your body. It is built to last, with high-quality materials and intuitive ergonomics. The Hypervolt Go 2 is designed to move conveniently wherever users are headed and includes features such as:
- Patented QuietGlide® technology for near silent operation
- Improved airflow and ventilation
- New LED speed sensors and back button control
- New ergonomic handle
- Battery level LED band
- Three speeds of powerful percussion
Go behind the design of the Hypervolt Go 2.
Katz continued: “Our mission from the beginning, was to put a percussion device in as many hands as possible. To do that, we need to continue to design products that are accessible to the widest possible audience of users. We also know, with the world opening back up, people are constantly on the move, and space can oftentimes be limited, so the smaller you can make the device, the more places you can take it, the more you can use it. Hypervolt Go 2 represents the next step towards achieving that goal.”
“My current phase of my career is about longevity and maintaining a competitive advantage,” said Kelly Slater, 11-time World Surf League champion and Hyperice Athlete-Investor. “To be my best when I’m competing, I have to also feel great no matter where I am, which is why I never leave home without the Hypervolt Go 2. It’s the ultimate in portability, it’s dead silent and it comes in clutch whether I’m preparing for a major event or just managing everyday aches.”
The Hypervolt Go 2 retails for $199 (£199; €229) and is now available in North America and other select regions. For more information, visit hyperice.com. To purchase, please visit country-specific sites: Canada, France, Germany, Italy, Portugal, Spain, UK and the United States.
To learn more about the Hypervolt Go 2, visit hyperice.com.
INTRODUCING: THE GO COLLECTIVE
To amplify the ethos of the Go line, Hyperice has assembled a diverse collection of individuals within #TeamHyperice who represent different industries and backgrounds who are pushing the boundaries of what it means to ‘go get it.’ The Go Collective seeks to make a movement out of movement across the many dimensions of fitness, fashion, lifestyle, sports, travel, longevity, wellness, art, family, and more. Through expansive storytelling and involvement in community initiatives and events, Hyperice hopes the Go Collective will inspire individuals everywhere to prioritize their daily wellness.
Meet the inaugural Go Collective members:
- Robin Arzón, Head Instructor and VP of Fitness Programming at Peloton
- Tony Finau, PGA TOUR Golfer
- Adrianne Ho, Model and Founder of Sweat The Style & The Farmers Market Global
- Joe Holder, Nike Master Trainer and Founder of The Ocho System™
- Alix Klineman, Beach Volleyball Olympic Gold Medalist
- Kelly Slater, Professional Surfer
- Nigel Sylvester, Pro BMX Athlete and Content Creator
- Raven B. Varona (Ravie B), Professional Photographer
“I’m proud to be a member of Hyperice’s new Go Collective because it represents a community for people who show up everyday for themselves and for others,” said Robin Arzón, Head Instructor and VP of Fitness Programming at Peloton. “I believe there is transformative power in movement and as a mom, wife and athlete, being able to be at my best in all dimensions of my life is what motivates me to ‘go get it’. Hyperice’s suite of products, and the Hypervolt Go 2 in particular, are my go-to wellness tools that help me be at my best each and every day.”
“I take my role as a husband and father of five even more seriously than my career as a pro golfer. There’s no doubt staying healthy is a huge part of my commitment to performance, but more importantly, it’s critical to me that I’m the best version of myself whenever I’m spending valuable time with my family,” said Tony Finau, PGA TOUR player and Hyperice investor. “The Hypervolt Go 2 goes with me everywhere – on the course during competition, training and recovery, and when I’m traveling between tournaments – to ensure that I can push to the limits of my full potential for years to come.”
“When it comes to feeling your best, a major part of that is making sure to move and to move effectively everyday, and recovery is a critical component of a holistic approach to an individual’s overall wellness,” said Joe Holder, Nike Master Trainer and Founder of The Ocho System™. “As someone who gets the opportunity to help so many people unlock their personal version of wellness, the Hypervolt Go 2 is an incredible tool for anyone to utilize to help ensure they can come back day after day - ready to be anything but average.”
To join the Go Collective community, follow Hyperice on social - instagram.com/hyperice and twitter.com/hyperice and sign up for emails on hyperice.com to unlock exclusive content, special offers, access to events and more. Learn more at: hyperice.com/newsroom/go-collective
About Hyperice
Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), mind technology (Core by Hyperice) and contrast therapy (Hyperice X). Now, as a holistic high-performance wellness brand, Hyperice is designed for all - from the most elite athletes, leagues and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance and workplace wellness on a global scale. Hyperice’s transformative acquisitions of Normatec, RecoverX and Core have helped to accelerate its innovation agenda as it enters its next stage of global growth. For more information, visit the newly redesigned hyperice.com.
1 Journal of Sports Science & Medicine 2020
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220404005376/en/
Contact information
Media Contact:
Jack Taylor PR
Nadine Hachicho
hyperice@jacktaylorpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
